Literature DB >> 8449016

Oral contraceptives and reproductive factors in multiple sclerosis incidence.

L Villard-Mackintosh1, M P Vessey.   

Abstract

Data from the Oxford.FPA prospective study show that oral contraceptive use and pregnancy have no discernible effect on the risk of developing multiple sclerosis (MS). Women of parity 0-2 developed MS twice as often as women of parity 3 or more but the difference did not reach statistical significance. Smoking may be a risk factor for developing MS. A nested case-control analysis did not identify any associations between MS onset and preceding illnesses.

Entities:  

Keywords:  Behavior; Biology; Case Control Studies; Central Nervous System; Central Nervous System Effects; Contraception; Contraceptive Methods; Demographic Factors; Developed Countries; England; Europe; Family Planning; Fertility; Fertility Measurements; Northern Europe; Oral Contraceptives; Parity; Physiology; Population; Population Dynamics; Pregnancy; Prospective Studies; Reproduction; Research Methodology; Research Report; Smoking; Studies; United Kingdom

Mesh:

Substances:

Year:  1993        PMID: 8449016     DOI: 10.1016/0010-7824(93)90088-o

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  32 in total

1.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis.

Authors:  Julie Dahl; Kjell-Morten Myhr; Anne Kjersti Daltveit; Nils Erik Gilhus
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

4.  Breastfeeding, ovulatory years, and risk of multiple sclerosis.

Authors:  Annette Langer-Gould; Jessica B Smith; Kerstin Hellwig; Edlin Gonzales; Samantha Haraszti; Corinna Koebnick; Anny Xiang
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

Review 5.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

Review 6.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

7.  Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.

Authors:  Natalia Palacios; Alvaro Alonso; Henrik Brønnum-Hansen; Alberto Ascherio
Journal:  Ann Epidemiol       Date:  2011-05-07       Impact factor: 3.797

Review 8.  The initiation and prevention of multiple sclerosis.

Authors:  Alberto Ascherio; Kassandra L Munger; Jan D Lünemann
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

9.  Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.

Authors:  A Alonso; S S Jick; M J Olek; M A Hernán
Journal:  J Neurol       Date:  2007-10-01       Impact factor: 4.849

Review 10.  Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Semin Immunopathol       Date:  2016-08-08       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.